Relentless Prescription Drug Price Increases

Affiliations

Editorial

Chaarushena Deb et al. JAMA. 2020.

. 2020 Mar 3;323(9):826-828.

doi: 10.1001/jama.2020.0359.

Erratum in

Error in Data in Study of Estimated Cost of Bringing a Drug to Market.
[No authors listed] [No authors listed] JAMA. 2022 Sep 20;328(11):1111. doi: 10.1001/jama.2022.14733. JAMA. 2022. PMID: 36125490 Free PMC article. No abstract available.

No abstract available

Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. Hernandez I, et al. JAMA. 2020 Mar 3;323(9):854-862. doi: 10.1001/jama.2020.1012. JAMA. 2020. PMID: 32125403 Free PMC article.
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.
Wouters OJ, McKee M, Luyten J. Wouters OJ, et al. JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166. JAMA. 2020. PMID: 32125404 Free PMC article.